Atalanta Sosnoff Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $617K | Sell |
5,960
-623
| -9% | -$55.6K | 0.01% | 73 |
|
|
2026
Q1 | $473K | Sell |
6,583
-44
| -0.7% | -$3.39K | 0.01% | 78 |
|
|
2025
Q4 | $526K | Sell |
6,627
-190
| -3% | -$15K | 0.01% | 74 |
|
|
2025
Q3 | $514K | Sell |
6,817
-153
| -2% | -$10.5K | 0.01% | 77 |
|
|
2025
Q2 | $481K | Buy |
6,970
+128
| +2% | +$8.39K | 0.01% | 74 |
|
|
2025
Q1 | $464K | Buy |
+6,842
| New | +$409K | 0.01% | 72 |
|
|
2023
Q1 | – | Sell |
-305,983
| Closed | -$28.5M | – | 115 |
|
|
2022
Q4 | $28.5M | Sell |
305,983
-321,530
| -51% | -$31M | 0.88% | 47 |
|
|
2022
Q3 | $59.8M | Sell |
627,513
-44,855
| -7% | -$4.44M | 1.89% | 20 |
|
|
2022
Q2 | $62.3M | Sell |
672,368
-26,234
| -4% | -$2.56M | 1.88% | 18 |
|
|
2022
Q1 | $70.7M | Buy |
698,602
+431,706
| +162% | +$45.4M | 1.65% | 16 |
|
|
2021
Q4 | $27.5M | Buy |
266,896
+264,081
| +9,381% | +$24.4M | 0.59% | 48 |
|
|
2021
Q3 | $239K | Buy |
+2,815
| New | +$236K | 0.01% | 87 |
|
|
2020
Q3 | – | Sell |
-504,073
| Closed | -$32.7M | – | 96 |
|
|
2020
Q2 | $32.7M | Sell |
504,073
-79,978
| -14% | -$5.04M | 0.99% | 37 |
|
|
2020
Q1 | $34.7M | Buy |
584,051
+5,767
| +1% | +$385K | 1.23% | 32 |
|
|
2019
Q4 | $43M | Sell |
578,284
-7,299
| -1% | -$512K | 1.28% | 30 |
|
|
2019
Q3 | $36.9M | Buy |
585,583
+411,353
| +236% | +$24.4M | 1.2% | 35 |
|
|
2019
Q2 | $9.49M | Buy |
+174,230
| New | +$9.38M | 0.3% | 62 |
|
|
2017
Q4 | – | Sell |
-6,570
| Closed | -$534K | – | 88 |
|
|
2017
Q3 | $534K | Sell |
6,570
-26,220
| -80% | -$2.07M | 0.02% | 68 |
|
|
2017
Q2 | $2.64M | Buy |
32,790
+2,588
| +9% | +$204K | 0.09% | 64 |
|
|
2017
Q1 | $2.37M | Buy |
30,202
+310
| +1% | +$24.7K | 0.08% | 67 |
|
|
2016
Q4 | $2.36M | Sell |
29,892
-55,326
| -65% | -$4.48M | 0.08% | 73 |
|
|
2016
Q3 | $7.58M | Sell |
85,218
-391,222
| -82% | -$36.9M | 0.26% | 65 |
|
|
2016
Q2 | $45.6M | Sell |
476,440
-25,855
| -5% | -$2.58M | 1.52% | 28 |
|
|
2016
Q1 | $52.1M | Sell |
502,295
-202,850
| -29% | -$19.7M | 1.64% | 25 |
|
|
2015
Q4 | $68.9M | Sell |
705,145
-336,524
| -32% | -$33M | 2.05% | 17 |
|
|
2015
Q3 | $101M | Sell |
1,041,669
-57,666
| -5% | -$6.06M | 3.21% | 5 |
|
|
2015
Q2 | $115M | Sell |
1,099,335
-230,935
| -17% | -$23.6M | 3.16% | 5 |
|
|
2015
Q1 | $137M | Sell |
1,330,270
-76,509
| -5% | -$7.74M | 3.66% | 3 |
|
|
2014
Q4 | $135M | Buy |
1,406,779
+98,344
| +8% | +$8.67M | 3.34% | 4 |
|
|
2014
Q3 | $104M | Sell |
1,308,435
-159,089
| -11% | -$12.5M | 2.58% | 12 |
|
|
2014
Q2 | $111M | Sell |
1,467,524
-692,564
| -32% | -$52.3M | 2.42% | 16 |
|
|
2014
Q1 | $162M | Buy |
2,160,088
+755,893
| +54% | +$53.4M | 3.61% | 2 |
|
|
2013
Q4 | $100M | Buy |
1,404,195
+313,557
| +29% | +$20.1M | 2.17% | 19 |
|
|
2013
Q3 | $61.9M | Sell |
1,090,638
-1,042,683
| -49% | -$62.1M | 1.63% | 31 |
|
|
2013
Q2 | $122M | Buy |
+2,133,321
| New | +$124M | 2.96% | 7 |
|
Other funds holding CVS
Atalanta Sosnoff Capital's CVS Position: Q2 2026 in Review
Atalanta Sosnoff Capital reduced its CVS Health (CVS) stake by 9.5% in Q2 2026, selling an estimated $55.6K and leaving 5,960 shares worth $617K. The position accounts for 0.01% of the portfolio, ranked #73.
Atalanta Sosnoff Capital first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $162M in Q1 2014. 2,055 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Atalanta Sosnoff Capital held 5,960 shares of CVS Health worth $617K as of Q2 2026.
- Atalanta Sosnoff Capital sold 623 CVS Health shares in Q2 2026, an estimated $55.6K.
- CVS Health made up 0.01% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #73 holding.
- Atalanta Sosnoff Capital first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
- Atalanta Sosnoff Capital's CVS Health position peaked at $162M in Q1 2014.
- 2,055 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.